United Therapeutics | UTHR - Ebitda



United Therapeutics reported $436.8M in EBITDA for its fiscal quarter ending in June of 2025.


Ebitda Change Date
Amarin USD -16025000 714K Mar/2025
Ardelyx USD -11872000 20.51M Jun/2025
Baxter International USD 325M 251M Mar/2025
Bayer EUR 236M 3.35B Jun/2025
Biogen USD 1.01B 456.5M Jun/2025
BioMarin Pharmaceutical USD 295.45M 49.49M Jun/2025
Gilead Sciences USD 3.4B 797M Jun/2025
GlaxoSmithKline GBP 3.18B 45M Jun/2025
Halozyme Therapeutics USD 225.5M 63.51M Jun/2025
Insmed USD -297127000 71.11M Jun/2025
Ionis Pharmaceuticals USD 150.23M 291.7M Jun/2025
J&J USD 7.88B 1.76B Mar/2025
Moderna USD -760000000 164M Jun/2025
Pfizer USD 5.32B 889M Jun/2025
PTC Therapeutics USD 971.14M 970.07M Mar/2025
Regeneron Pharmaceuticals USD 1.66B 926.5M Jun/2025
Sarepta Therapeutics USD 126.42M 416.82M Jun/2025
Teva Pharmaceutical Industries USD 1.23B 124M Jun/2025
United Therapeutics USD 436.8M 34.2M Jun/2025
Vertex Pharmaceuticals USD 1.34B 556.6M Jun/2025